Agostini C, Trentin L, Zambello R, Bulian P, Caenazzo C, Cipriani A, Cadrobbi P, Garbisa S, Semenzato G
Padua University School of Medicine, Department of Clinical Medicine, Italy.
J Immunol. 1992 Nov 15;149(10):3379-85.
In this paper, the release of granulocyte-macrophage colony-stimulating factor (GM-CSF) in the lung of patients with HIV-1 infection was evaluated. This cytokine has well recognized effects on granulocyte and macrophage growth and differentiation and plays some role in the mechanisms leading to the accumulation of alveolar macrophages (AM) in patients with interstitial lung disease. Detectable levels of GM-CSF (up to 10 pg/ml) were demonstrated in unconcentrated bronchoalveolar lavage fluid retrieved from HIV-1-seropositive patients, thus suggesting that the GM-CSF is released in vivo in the lung during HIV-1 infection. A statistically significant correlation was demonstrated between the bronchoalveolar lavage concentrations of GM-CSF and the absolute numbers of AM and lung neutrophils. Cell-free supernatants obtained from unstimulated 24-h cultured AM isolated from HIV-1-infected patients contained discrete amounts of GM-CSF, as demonstrated by an immunoenzymatic assay. AM lost the capability of releasing GM-CSF after 72 h of culture, thus suggesting that the production of GM-CSF is not constitutive in AM. After exposition of AM with LPS, the release of GM-CSF and the expression of its mRNA significantly increased with respect to the baseline values; interestingly, the amount of GM-CSF released by LPS-stimulated AM was more than 10-fold higher in HIV-1-infected patients than in healthy subjects. As demonstrated by flow cytometry analysis, more than 70% of freshly isolated AM efficiently bound phycoerythrin-GM-CSF, thus indicating that they express the receptor for GM-CSF. Determination of AM in G1, S, and G2+M by flow cytometry showed that, after 48 h of culture with GM-CSF, 5.5 to 7% of AM entered the proliferative phase of the cell cycle. Taken together, these findings suggest that AM might represent an important source of GM-CSF production in HIV-1 infection. In particular, the hypothesis is formulated that pulmonary opportunists might trigger AM to synthesize GM-CSF in situ. The local overproduction of this cytokine is likely to play a role in the pathogenic events leading to the local proliferation of AM and recruitment of neutrophils in AIDS-associated interstitial lung disease.
本文评估了HIV-1感染患者肺部粒细胞-巨噬细胞集落刺激因子(GM-CSF)的释放情况。这种细胞因子对粒细胞和巨噬细胞的生长及分化具有公认的作用,并且在间质性肺病患者肺泡巨噬细胞(AM)积聚的机制中发挥一定作用。在从HIV-1血清阳性患者获取的未浓缩支气管肺泡灌洗液中检测到了可检测水平的GM-CSF(高达10 pg/ml),这表明在HIV-1感染期间GM-CSF在肺部于体内释放。GM-CSF的支气管肺泡灌洗浓度与AM和肺中性粒细胞的绝对数量之间存在统计学上的显著相关性。通过免疫酶测定法证明,从HIV-1感染患者分离的未刺激培养24小时的AM获得的无细胞上清液中含有一定量的GM-CSF。AM在培养72小时后失去了释放GM-CSF的能力,这表明GM-CSF的产生在AM中不是组成性的。用脂多糖(LPS)刺激AM后,GM-CSF的释放及其mRNA的表达相对于基线值显著增加;有趣的是,LPS刺激的AM释放的GM-CSF量在HIV-1感染患者中比在健康受试者中高出10倍以上。通过流式细胞术分析表明,超过70%的新鲜分离的AM能有效结合藻红蛋白-GM-CSF,这表明它们表达GM-CSF受体。通过流式细胞术测定处于G1、S和G2+M期的AM表明,在用GM-CSF培养48小时后,5.5%至7%的AM进入细胞周期的增殖期。综上所述,这些发现表明AM可能是HIV-1感染中GM-CSF产生的重要来源。特别是,提出了这样的假设,即肺部机会性感染病原体可能触发AM在原位合成GM-CSF。这种细胞因子的局部过量产生可能在导致AM局部增殖和艾滋病相关间质性肺病中中性粒细胞募集的致病过程中起作用。